£107.98

Humana Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Price data last checked 28 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 63 days • 63 data points (No recent data available)

Historical
Generating forecast...
£107.98 £107.20 £107.37 £107.54 £107.71 £107.88 £108.05 10 April 2026 25 April 2026 11 May 2026 26 May 2026 11 June 2026

Price Distribution

Price distribution over 63 days • 2 price levels

Days at Price
Current Price
18 days 45 days · current 0 11 23 34 45 £107 £108 Days at Price

Price Analysis

Most common price: £108 (45 days, 71.4%)

Price range: £107 - £108

Price levels: 2 different prices over 63 days

Description

Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia (ALL). These advances have dramatically improved the management of patients with relapsed refractory lymphoma, myeloma and leukemia. Gene and Cellular Immunotherapy for Cancer offers readers a comprehensive review of current cellular and gene-based immunotherapies. Divided into eighteen cohesive chapters, this book provides an in-depth and detailed look into cellular-based immunotherapies including CAR-T, TCR-T, TIL, Viral CTLs, NK cells in addition to T/NK cell engagers, focusing on their historical perspectives, biology, development and manufacturing, toxicities and more. Edited by two leading experts on gene and cellular immunotherapy, the book will feature chapters written by a diverse collection of recognized and up-and-coming experts and researchers in the field, providing oncologists, immunologists, researchers and clinical and basic science trainees with a bench to bedside view of the latest developments in the field.

Product Specifications

Brand
Humana
Format
paperback
Domain
Amazon UK
Release Date
21 December 2022
Listed Since
01 December 2022

Barcode

No barcode data available

Similar Products You Might Like

Cancer Gene Therapy (Contemporary Cancer Research)
88% match

Cancer Gene Therapy (Contemporary Cancer Research)

Humana

£146.46 31 May 2026
Experimental and Applied Immunotherapy
87% match

Experimental and Applied Immunotherapy

Humana

£140.31 04 May 2026
Experimental and Applied Immunotherapy
86% match

Experimental and Applied Immunotherapy

Humana

£118.30 04 Jun 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
86% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£103.24 25 May 2026
Biologic Therapy of Leukemia (Contemporary Hematology)
85% match

Biologic Therapy of Leukemia (Contemporary Hematology)

Humana

£73.10 15 Jun 2026
Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)
85% match

Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)

Humana

£107.57 26 May 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
85% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£108.92 10 Jun 2026
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
85% match

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Humana

£141.86 31 May 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
84% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.46 31 May 2026
Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
84% match

Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Humana

£148.05 25 May 2026
Brain Tumor Immunotherapy
84% match

Brain Tumor Immunotherapy

Humana

£129.72 03 Jun 2026
Chemokines and Cancer (Contemporary Cancer Research)
84% match

Chemokines and Cancer (Contemporary Cancer Research)

Humana

£120.92 31 May 2026
Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)
83% match

Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)

Humana

£77.90 25 May 2026
Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)
83% match

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)

Humana

£80.64 25 May 2026
Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)
83% match

Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£142.42 26 May 2026
Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)
83% match

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Humana

£107.98 29 May 2026
Immunotherapy for Gastrointestinal Cancer
83% match

Immunotherapy for Gastrointestinal Cancer

Springer

£99.03 05 Jun 2026
NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)
83% match

NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)

Academic Press

£111.99 26 May 2026
Gene Therapy of Solid Cancers: Methods and Protocols: 1317 (Methods in Molecular Biology, 1317)
83% match

Gene Therapy of Solid Cancers: Methods and Protocols: 1317 (Methods in Molecular Biology, 1317)

Humana

£73.56 25 May 2026
Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)
82% match

Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)

Humana

£73.10 01 Jun 2026
Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development)
82% match

Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£145.23 01 Jun 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
82% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£107.98 29 May 2026
Biopharmaceutical Drug Design and Development
82% match

Biopharmaceutical Drug Design and Development

Humana

£108.92 20 May 2026
Immunotherapy for Pediatric Malignancies
82% match

Immunotherapy for Pediatric Malignancies

Springer

£113.90 05 Jun 2026